HongKong Jingang Trade Holding Company Limited entered into the Share Purchase Agreement to acquire 30.89% stake in Ausnutria Dairy Corporation Ltd (SEHK:1717) from Citagri Easter Ltd, Bioengine Capital Inc., Center Laboratories, Inc. (TPEX:4123) and Bartle van der Meer for HKD 5.3 billion on October 27, 2021. Under the terms HongKong Jingang Trade Holding Company Limited will acquire 530.8 million shares for HKD10.06 per share. Consideration of HKD 2.88 billion to CEL in respect of 286,599,262 Shares, representing approximately 16.68% and 15.85% of the issued share capital of Ausnutria Dairy Corporation Ltd sthe issued share capital of Ausnutria Dairy Corporation Ltd as at the date of this joint announcement and as enlarged by the issue and allotment of the Subscription Shares respectively. Post completion CEL will be interested in 92,400,738 Shares, representing approximately 5.38% and 5.11% of the issued share capital of Ausnutria Dairy Corporation Ltdas at the date of this joint announcement and as enlarged by the issue and allotment of the Subscription Shares respectively, CL Seller (BioEngine) will not retain any Shares, CL Seller (CenterLab) will be interested in 130,706,271 Shares, representing approximately 7.61% and 7.23% of the issued share capital of Ausnutria Dairy Corporation Ltd as at the date of this joint announcement and as enlarged by the issue and allotment of the Subscription Shares respectively and DDI Seller will be interested in 93,205,230 Shares, representing approximately 5.42% and 5.15% of the issued share capital of Ausnutria Dairy Corporation Ltd as at the date of this joint announcement and as enlarged by the issue and allotment of the Subscription Shares respectively.

The Share Purchase Completion is subject to the satisfaction (or waiver, where applicable) of the following conditions on or before the Long Stop Date-i) with respect to the Offeror's obligations to consummate the Share Purchase Completion only, the warranties given by each Vendor or Vendor Group are true and accurate as of the date of the Share Purchase Agreement and as of the Completion Date by reference to the facts and circumstances then subsisting ii) Transaction having been cleared by the SFC, and published on the Stock Exchange's website by the Company and the Offeror iii) the receipt of all consents, clearances, approvals, permissions, license, authorization and waivers required to be obtained from, and all registrations, applications, notices and filings required to be made with or provided to, any governmental authority under or in connection with any applicable laws, in connection with the implementation of the Share Purchase Agreement. iii) the Subscription Agreement is consummated in accordance with the terms and conditions thereunder and simultaneously with the Share Purchase Completion. As on December 8, 2021, HongKong Jingang Trade Holding Company Limited has submitted the filings to State Administration for Market Regulation of the People's Republic of China and obtained antitrust clearance from the SAMR. HongKong Jingang has submitted the filings to the Ministry of Commerce of the PRC and the NDRC, and is waiting for their response to the filings. After receiving clearance from the Ministry of Commerce of the PRC and the NDRC, HongKong Jingang will submit the filings to SAFE. As on January 10, 2022, the transaction cleared by the SFC and filings with and receipt of clearances from the State Administration for Market Regulation of the PRC or its local counterparts for merger review. filings with the Ministry of Commerce of the PRC, the NDRC, the SAFE, or their local counterparts for overseas investment has been submitted.

Share Purchase Completion will take place within five Business Days after all conditions precedent to the Share Purchase Agreement are satisfied or waived or any such other date as each of the Vendors and Offeror may agree in writing. The log stop date is June 30, 2022.

HongKong Jingang Trade Holding Company Limited completed the acquisition of 30.89% stake in Ausnutria Dairy Corporation Ltd (SEHK:1717) from Citagri Easter Ltd, Bioengine Capital Inc., Center Laboratories, Inc. (TPEX:4123) and Bartle van der Meer on January 28, 2022.